Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04874610 · ClinicalTrials.gov registry record
Steroid Metabolism in Obese and Non-Obese Pediatric Patients Hospitalized for Status Asthmaticus
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 15
- Enrollment target
NCT04874610 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 15 participants.
The verdict
NCT04874610 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
Single center, open-label, non-randomized study to assess the pharmacokinetic profile of methylprednisolone in healthy children 2-20 years of age admitted for asthma exacerbation.
Interventions
- DRUG Methylprednisolone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2021-08-16 |
| Est. Completion | 2022-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04874610
The ClinicalTrials.gov registry entry for NCT04874610 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Methylprednisolone is the first listed.
NCT04874610 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04874610 about?
NCT04874610 is a clinical study titled "Steroid Metabolism in Obese and Non-Obese Pediatric Patients Hospitalized for Status Asthmaticus". Single center, open-label, non-randomized study to assess the pharmacokinetic profile of methylprednisolone in healthy children 2-20 years of age admitted for asthma exacerbation.
What is the current status of trial NCT04874610?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2021-08-16. Estimated completion is 2022-03-31.
What interventions are being tested in trial NCT04874610?
The interventions under investigation include: Methylprednisolone (DRUG).
Who is sponsoring clinical trial NCT04874610?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.